Left Atrial Appendage Occlusion for Patients with Transcatheter Aortic Valve Replacement, MitraClip, Percutaneous Coronary Intervention, and Ablation for Atrial Fibrillation: Optimizing Long-Term Patient Outcomes

Publication date: March 2020Source: Cardiac Electrophysiology Clinics, Volume 12, Issue 1Author(s): Amar Krishnaswamy, Oussama Wazni, Samir R. Kapadia
Source: Cardiac Electrophysiology Clinics - Category: Cardiology Source Type: research

Related Links:

ConclusionPredicting overall readmissions after open ‐heart valve surgery is difficult as causes of readmissions vary and different causes are associated with different characteristics. Future studies should target reducing cause‐specific readmissions.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ORIGINAL ARTICLE Source Type: research
AbstractPurpose of ReviewThis review aims to describe the current evidence and consensus recommendations around antiplatelet and anticoagulant management in three common clinical scenarios in transcatheter aortic valve replacement (TAVR): (1) recent percutaneous coronary intervention (PCI) preceding TAVR, (2) atrial fibrillation (AF) management in patients undergoing TAVR, and (3) bioprosthetic valve thrombosis management in TAVR.Recent FindingsSeveral small clinical trials have evaluated the use of single vs. dual antiplatelet therapy in patients undergoing TAVR, with most recent data favoring single antiplatelet therapy....
Source: Current Cardiology Reports - Category: Cardiology Source Type: research
Abstract Catheter-based interventions have revolutionized treatment of both coronary artery disease and aortic valve disease. Yet, these procedures are accompanied by thromboembolic and bleeding complications. Antiplatelet agents and anticoagulants with tolerable risk of bleeding complications are required to protect from recurrent thromboembolic events. Although guidelines for antithrombotic treatment in patients undergoing percutaneous coronary intervention (PCI) and transcatheter aortic valve replacement (TAVR) are available, scarce evidence exists regarding therapeutic recommendations for patients at high risk...
Source: Hamostaseologie - Category: Hematology Authors: Tags: Hamostaseologie Source Type: research
This article provides an update on three randomized controlled trials of rivaroxaban, a direct, oral factor Xa inhibitor, that are complete or are ongoing, in these unmet areas of stroke prevention: oPen-label, randomized, controlled, multicentre study explorIng twO treatmeNt stratEgiEs of Rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in patients with Atrial Fibrillation who undergo Percutaneous Coronary Intervention (PIONEER AF-PCI) trial; the New Approach riVaroxaban Inhibition of factor Xa in a Global trial vs Aspirin to prevenT Embolism in Embolic Stroke of Undetermined Source (NAVIGATE E...
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Tags: Thromb Haemost Source Type: research
Publication date: March 2018 Source:Canadian Journal of Cardiology, Volume 34, Issue 3 Author(s): Shamir R. Mehta, Kevin R. Bainey, Warren J. Cantor, Marie Lordkipanidzé, Guillaume Marquis-Gravel, Simon D. Robinson, Matthew Sibbald, Derek Y. So, Graham C. Wong, Joseph G. Abunassar, Margaret L. Ackman, Alan D. Bell, Raymond Cartier, James D. Douketis, Patrick R. Lawler, Michael S. McMurtry, Jacob A. Udell, Sean van Diepen, Subodh Verma, G.B. John Mancini, John A. Cairns, Jean-François Tanguay Antiplatelet therapy (APT) has become an important tool in the treatment and prevention of atherosclerotic events, par...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Conclusions Intermediate to high-risk women enrolled in this first ever all-women contemporary TAVR registry experienced a 1-year VARC-2 composite efficacy endpoint of 16.5%, with a low incidence of 1-year mortality and stroke. Prior revascularization and EuroSCORE I were independent predictors of the VARC-2 efficacy endpoint, whereas EuroSCORE I, baseline atrial fibrillation, and prior percutaneous coronary intervention were independent predictors of the 1-year death or stroke.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - Category: Cardiology Authors: Tags: Focus on Cardiovascular Outcomes Among Women Source Type: research
Publication date: Available online 19 December 2017 Source:Canadian Journal of Cardiology Author(s): Shamir R. Mehta, Kevin R. Bainey, Warren J. Cantor, Marie Lordkipanidzé, Guillaume Marquis-Gravel, Simon D. Robinson, Matthew Sibbald, Derek Y. So, Graham C. Wong, Joseph G. Abunassar, Margaret L. Ackman, Alan D. Bell, Raymond Cartier, James D. Douketis, Patrick R. Lawler, Michael S. McMurtry, Jacob A. Udell, Sean van Diepen, Subodh Verma, G.B. John Mancini, John A. Cairns, Jean-François Tanguay, Paul W. Armstrong, Akshay Bagai, Claudia Bucci, Jean-Pierre Déry, Jean Diodati, Jocelyn Dupuis, David Fitch...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Time limit: 0 Quiz-summary 0 of 20 questions completed Questions: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Information This test series requires login for attempting. You can login easily with your Facebook account (Use the CONNECT WITH icon on the upper part of right sidebar displaying t...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: General Cardiology Source Type: blogs
This article will introduce and provide context for these RCTs in the contemporary management of arterial and venous thromboembolism in the following underserved areas: Patients with both NVAF and acute coronary syndrome (ACS) requiring percutaneous coronary intervention (PCI); patients with embolic stroke of undetermined source (ESUS); patients who require transcatheter aortic valve replacement (TAVR); patients with acute or chronic coronary artery disease (CAD; including those with heart failure [HF]); those at risk of or suffering from cancer-associated thrombosis (CAT) and those requiring long-term anticoagulation. It ...
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Tags: Thromb Haemost Source Type: research
Please wait while the activity loads. If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled. If loading fails, click here to try again Click on the 'Start' button to begin the mock test. After answering all questions, click on the 'Get Results' button to display your score and the explanations. There is no time limit for this mock test. Start Congratulations - you have completed DM / DNB Cardiology Entrance Mock Test 21. You scored %%SCORE%% out of %%TOTAL%%. Your performance has been rat...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Featured Source Type: blogs
More News: Angioplasty | Atrial Fibrillation | Cardiology | Coronary Angioplasty | Heart Valve Surgery | Percutaneous Coronary Intervention